Evidence map›Paper›PMID 41964784›Full record

ArticleJournal of endocrinological investigation2026

Lipocalin 2 promotes papillary thyroid cancer progression through activation of glycolysis via Hippo/YAP1/HIF1α axis.

Xiaoyu Qian, Jian Tang, Liehao Jiang, Lin Li, Chao Shen, Lisong Teng

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoyu QianDepartment of Surgical Oncology, The First Affliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jian TangDepartment of Head and Neck Surgery, The First Hospital of Jiaxing, The Affiliated Hospital of Jiaxing University, Jiaxing, China.
Liehao JiangDepartment of Head and Neck Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China.
Lin LiDepartment of Nuclear Medicine Clinic, The First Hospital of Jiaxing, The Affiliated Hospital of Jiaxing University, Jiaxing, China.
Chao ShenDepartment of Head and Neck Surgery, The First Hospital of Jiaxing, The Affiliated Hospital of Jiaxing University, Jiaxing, China.
Lisong TengDepartment of Surgical Oncology, The First Affliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. lsteng@zju.edu.cn.

Funding

Jiaxing Key Discipline of Traditional Chinese Medicine Surgery of Traditional Chinese Medicine 2023-ZYYCX-002Jiaxing Provinces and Cities Jointly Cultivate Discipline - -General Surgery (Minimally Invasive) 2023-PYXK-001National Oncology Clinical Key Speciality 2023-GJZK-001The medical and health science and technology project of Zhejiang Province( 2025KY347
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlycolysisGrowthLCN2MetastasisPapillary thyroid carcinoma

Identifiers

PMID41964784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.